iifl-logo

Syncom Formulations (India) Ltd Board Meeting

19.9
(0.76%)
May 21, 2025|12:59:56 PM

Syncom Formul. CORPORATE ACTIONS

21/05/2024calendar-icon
21/05/2025calendar-icon
PurposeBoard Meetings DateAnnouncement Date
Board Meeting19 May 202513 May 2025
Syncom Formulations India Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2025 inter alia to consider and approve a) To consider and approve Standalone and Consolidated Audited Financial Results of the Company for the Quarter and year ended 31st March 2025; b) To take on record the Standalone and Consolidated Audit Report by Auditors for the Audited Financial Results of the Company for the Quarter and year ended 31st March 2025. c) To consider and approve other matter incidental thereto Pursuant to Regulation 33(3)(d) of SEBI (LODR) Regulations, 2015, we are pleased to submit the Standalone & Consolidated Audited Financial Results along with Auditors Report thereon by Statutory Auditors, Statement of Assets and Liabilities and Cash Flow for the quarter/year ended on 31st March, 2025, in PDF Format, which were approved by the Audit Committee and Board of Directors at their meeting held on Monday, 19th May, 2025. (As Per BSE Announcement dated on 19.05.2025)
Board Meeting10 Feb 202510 Feb 2025
Consideration and approval of standalone and consolidated unaudited financial results for the quarter and nine months ended 31.12.2024
Board Meeting11 Nov 20244 Nov 2024
SYNCOM FORMULATIONS (INDIA) LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2024 inter alia to consider and approve Pursuant to Regulation 29(1) (a) of SEBI (LODR) Regulations 2015 read with SEBI (PIT) Regulations 2015 as amended from time to time we are pleased to inform that 3/2024-25 Meeting of the Board of Directors of the Company is scheduled to be held on Monday the 11th day of November 2024 at 4:00 P.M. at the Corporate Office situated at 207 Saket Nagar Near Saket Club Indore (M.P.) 452018. Submission of Financials for the Half year ended 30.09.2024 (As Per BSE Announcement dated on 11.11.2024)
Board Meeting12 Aug 20242 Aug 2024
SYNCOM FORMULATIONS (INDIA) LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2024 inter alia to consider and approve Pursuant to Regulation 29(1) (a) of SEBI (LODR) Regulations 2015 read with SEBI (PIT) Regulations 2015 as amended from time to time we are pleased to inform that 2/2024-25 Meeting of the Board of Directors of the Company is scheduled to be held on Monday the 12th day of August 2024at 4:00 P.M. at the Corporate Office situated at 207 Saket Nagar Near Saket Club Indore (M.P.) 452018 Submission of Unaudited Standalone and Consolidated financial Results for the quarter ended 30.06.2024 (As Per BSE Announcement Dated on: 12/08/2024)

Syncom Formul.: Related News

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTOR

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.